Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial

X-linked chronic granulomatous disease (CGD) is an inherited immunodeficiency caused by a defect in the gp91phox gene. In an effort to treat X-CGD, we investigated the safety and efficacy of gene therapy using a retroviral vector, MT-gp91. Two X-CGD patients received autologous CD34+ cells transduce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kang, Hyoung Jin (VerfasserIn) , Bartholomä, Cynthia C. (VerfasserIn) , Paruzynski, Anna (VerfasserIn) , Arens, Anne (VerfasserIn) , Kim, Sujeong (VerfasserIn) , Yu, Seung Shin (VerfasserIn) , Hong, Youngtae (VerfasserIn) , Joo, Chang-Wan (VerfasserIn) , Yoon, Nam-Kyung (VerfasserIn) , Rhim, Jung-Woo (VerfasserIn) , Kim, Joong Gon (VerfasserIn) , Kalle, Christof von (VerfasserIn) , Schmidt, Manfred (VerfasserIn) , Kim, Sunyoung (VerfasserIn) , Ahn, Hyo Seop (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 August 2011
In: Molecular therapy
Year: 2011, Jahrgang: 19, Heft: 11, Pages: 2092-2101
ISSN:1525-0024
DOI:10.1038/mt.2011.166
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/mt.2011.166
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1525001616328076
Volltext
Verfasserangaben:Hyoung Jin Kang, Cynthia C Bartholomae, Anna Paruzynski, Anne Arens, Sujeong Kim, Seung Shin Yu, Youngtae Hong, Chang-Wan Joo, Nam-Kyung Yoon, Jung-Woo Rhim, Joong Gon Kim, Christof Von Kalle, Manfred Schmidt, Sunyoung Kim and Hyo Seop Ahn

MARC

LEADER 00000caa a2200000 c 4500
001 1809682126
003 DE-627
005 20220820220854.0
007 cr uuu---uuuuu
008 220711s2011 xx |||||o 00| ||eng c
024 7 |a 10.1038/mt.2011.166  |2 doi 
035 |a (DE-627)1809682126 
035 |a (DE-599)KXP1809682126 
035 |a (OCoLC)1341463690 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kang, Hyoung Jin  |e VerfasserIn  |0 (DE-588)1262247063  |0 (DE-627)1809683955  |4 aut 
245 1 0 |a Retroviral gene therapy for X-linked chronic granulomatous disease  |b results from phase I/II trial  |c Hyoung Jin Kang, Cynthia C Bartholomae, Anna Paruzynski, Anne Arens, Sujeong Kim, Seung Shin Yu, Youngtae Hong, Chang-Wan Joo, Nam-Kyung Yoon, Jung-Woo Rhim, Joong Gon Kim, Christof Von Kalle, Manfred Schmidt, Sunyoung Kim and Hyo Seop Ahn 
264 1 |c 30 August 2011 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.07.2022 
520 |a X-linked chronic granulomatous disease (CGD) is an inherited immunodeficiency caused by a defect in the gp91phox gene. In an effort to treat X-CGD, we investigated the safety and efficacy of gene therapy using a retroviral vector, MT-gp91. Two X-CGD patients received autologous CD34+ cells transduced with MT-gp91 after a conditioning regimen consisting of fludarabine and busulfan. The level of gene-marked cells was highest at day 21 (8.3 and 11.7% in peripheral blood cells) but decreased to 0.08 and 0.5%, respectively, 3 years after gene transfer. The level of functionally corrected cells, as determined by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase assay, reached a peak at day 17 (6.5% patient 1 (P1) and 14.3% patient 2 (P2) of total granulocytes) and declined to 0.05% (P1) and 0.21% (P2), 3 years later. Some retroviral vectors were found to have integrated within or close to the proto-oncogenes MDS1-EVI1, PRDM16, and CCND2; however, no abnormal cell expansion or related hematological malignancy was observed. Overall, the gene transfer procedure did not produce any serious adverse effects and was able to convert a significant fraction of blood cells to biologically functional cells, albeit for a short period of time. 
700 1 |a Bartholomä, Cynthia C.  |e VerfasserIn  |0 (DE-588)1036481042  |0 (DE-627)751079243  |0 (DE-576)384489524  |4 aut 
700 1 |a Paruzynski, Anna  |e VerfasserIn  |0 (DE-588)142778648  |0 (DE-627)640120822  |0 (DE-576)333342526  |4 aut 
700 1 |a Arens, Anne  |d 1980-  |e VerfasserIn  |0 (DE-588)1030235244  |0 (DE-627)734950039  |0 (DE-576)378039490  |4 aut 
700 1 |a Kim, Sujeong  |e VerfasserIn  |4 aut 
700 1 |a Yu, Seung Shin  |e VerfasserIn  |4 aut 
700 1 |a Hong, Youngtae  |e VerfasserIn  |4 aut 
700 1 |a Joo, Chang-Wan  |e VerfasserIn  |4 aut 
700 1 |a Yoon, Nam-Kyung  |e VerfasserIn  |4 aut 
700 1 |a Rhim, Jung-Woo  |e VerfasserIn  |4 aut 
700 1 |a Kim, Joong Gon  |e VerfasserIn  |4 aut 
700 1 |a Kalle, Christof von  |d 1962-  |e VerfasserIn  |0 (DE-588)1036481115  |0 (DE-627)75107926X  |0 (DE-576)168957396  |4 aut 
700 1 |a Schmidt, Manfred  |d 1967-2022  |e VerfasserIn  |0 (DE-588)122922301  |0 (DE-627)706092430  |0 (DE-576)293477620  |4 aut 
700 1 |a Kim, Sunyoung  |e VerfasserIn  |4 aut 
700 1 |a Ahn, Hyo Seop  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 19(2011), 11, Seite 2092-2101  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a Retroviral gene therapy for X-linked chronic granulomatous disease results from phase I/II trial 
773 1 8 |g volume:19  |g year:2011  |g number:11  |g pages:2092-2101  |g extent:10  |a Retroviral gene therapy for X-linked chronic granulomatous disease results from phase I/II trial 
856 4 0 |u https://doi.org/10.1038/mt.2011.166  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1525001616328076  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220711 
993 |a Article 
994 |a 2011 
998 |g 122922301  |a Schmidt, Manfred  |m 122922301:Schmidt, Manfred  |d 140000  |e 140000PS122922301  |k 0/140000/  |p 13 
998 |g 1036481115  |a Kalle, Christof von  |m 1036481115:Kalle, Christof von  |d 910000  |e 910000PK1036481115  |k 0/910000/  |p 12 
998 |g 1030235244  |a Arens, Anne  |m 1030235244:Arens, Anne  |d 50000  |e 50000PA1030235244  |k 0/50000/  |p 4 
998 |g 142778648  |a Paruzynski, Anna  |m 142778648:Paruzynski, Anna  |d 140000  |e 140000PP142778648  |k 0/140000/  |p 3 
998 |g 1036481042  |a Bartholomä, Cynthia C.  |m 1036481042:Bartholomä, Cynthia C.  |d 140000  |e 140000PB1036481042  |k 0/140000/  |p 2 
999 |a KXP-PPN1809682126  |e 416377193X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Retroviral gene therapy for X-linked chronic granulomatous disease","subtitle":"results from phase I/II trial","title":"Retroviral gene therapy for X-linked chronic granulomatous disease"}],"person":[{"given":"Hyoung Jin","role":"aut","family":"Kang","display":"Kang, Hyoung Jin"},{"display":"Bartholomä, Cynthia C.","family":"Bartholomä","given":"Cynthia C.","role":"aut"},{"given":"Anna","role":"aut","family":"Paruzynski","display":"Paruzynski, Anna"},{"given":"Anne","role":"aut","family":"Arens","display":"Arens, Anne"},{"given":"Sujeong","role":"aut","family":"Kim","display":"Kim, Sujeong"},{"role":"aut","given":"Seung Shin","family":"Yu","display":"Yu, Seung Shin"},{"given":"Youngtae","role":"aut","family":"Hong","display":"Hong, Youngtae"},{"given":"Chang-Wan","role":"aut","family":"Joo","display":"Joo, Chang-Wan"},{"display":"Yoon, Nam-Kyung","given":"Nam-Kyung","role":"aut","family":"Yoon"},{"display":"Rhim, Jung-Woo","given":"Jung-Woo","role":"aut","family":"Rhim"},{"family":"Kim","given":"Joong Gon","role":"aut","display":"Kim, Joong Gon"},{"given":"Christof von","role":"aut","family":"Kalle","display":"Kalle, Christof von"},{"display":"Schmidt, Manfred","family":"Schmidt","given":"Manfred","role":"aut"},{"display":"Kim, Sunyoung","given":"Sunyoung","role":"aut","family":"Kim"},{"family":"Ahn","given":"Hyo Seop","role":"aut","display":"Ahn, Hyo Seop"}],"physDesc":[{"extent":"10 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"30 August 2011","dateIssuedKey":"2011"}],"id":{"eki":["1809682126"],"doi":["10.1038/mt.2011.166"]},"recId":"1809682126","name":{"displayForm":["Hyoung Jin Kang, Cynthia C Bartholomae, Anna Paruzynski, Anne Arens, Sujeong Kim, Seung Shin Yu, Youngtae Hong, Chang-Wan Joo, Nam-Kyung Yoon, Jung-Woo Rhim, Joong Gon Kim, Christof Von Kalle, Manfred Schmidt, Sunyoung Kim and Hyo Seop Ahn"]},"note":["Gesehen am 11.07.2022"],"relHost":[{"language":["eng"],"pubHistory":["1.2000 -"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 28.05.2020"],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"American Society of Gene Therapy"}],"title":[{"subtitle":"official journal of the American Society of Gene Therapy","title":"Molecular therapy","title_sort":"Molecular therapy"}],"disp":"Retroviral gene therapy for X-linked chronic granulomatous disease results from phase I/II trialMolecular therapy","recId":"320415198","part":{"volume":"19","pages":"2092-2101","extent":"10","text":"19(2011), 11, Seite 2092-2101","issue":"11","year":"2011"},"origin":[{"publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla.","dateIssuedDisp":"2000-","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","dateIssuedKey":"2000"}],"id":{"eki":["320415198"],"issn":["1525-0024"],"zdb":["2001818-6"]}}]} 
SRT |a KANGHYOUNGRETROVIRAL3020